Literature DB >> 11369004

Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells.

Y Huang1, L Song, S Wu, F Fan, M F Lopes-Virella.   

Abstract

We have reported recently that oxidized low-density lipoprotein (oxLDL) stimulates matrix metalloproteinase-1 (MMP-1) expression in human vascular endothelial cells. The present study was conducted to examine the effect of oxLDL on expression of Tissue inhibitor of metalloproteinase-1 (TIMP-1), an endogenous inhibitor of MMPs, in human vascular endothelial cells. Our enzyme-linked immunosorbent assay and Northern blot analysis showed that oxLDL inhibited TIMP-1 secretion and expression by human umbilical vein endothelial cells. In contrast, PMA stimulated TIMP-1 expression and secretion. Both oxLDL and PMA increased MMP-1 expression and secretion significantly as previously reported. Inhibition by oxLDL of TIMP-1 expression was also observed in human aortic endothelial cells. Collagenase activity as detected by an enzymatic activity assay demonstrated, as expected, an increase in collagenase activity in the culture medium from oxLDL-treated cells as compared with that from untreated cells. The presented data indicates that oxLDL differentially regulates TIMP-1 and MMP-1 expression, whereas PMA coordinately regulates TIMP-1 and MMP-1 in vascular endothelial cells. The lack of coordination in the secretion of MMP-1 and TIMP-1 induced by oxLDL leads to an increased collagen-degrading activity that may contribute to destabilization of atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369004     DOI: 10.1016/s0021-9150(00)00638-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

2.  HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents.

Authors:  A Paez; A R Méndez-Cruz; E Varela; E Rodriguez; J Guevara; L Flores-Romo; L F Montaño; F A Massó
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Tore Henriksen; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-05-16       Impact factor: 5.614

Review 4.  Ceramide: a common pathway for atherosclerosis?

Authors:  Jean Bismuth; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2007-10-25       Impact factor: 5.162

5.  Effect of Gastrodia elata on tumor necrosis factor-alpha-induced matrix metalloproteinase activity in endothelial cells.

Authors:  Yun Jung Lee; Sun Mi Hwang; Dae Gill Kang; Jin Sook Kim; Ho Sub Lee
Journal:  J Nat Med       Date:  2009-08-12       Impact factor: 2.343

6.  Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes.

Authors:  Bernal-Lopez M Rosa; Llorente-Cortes Vicenta; Gomez-Carrillo Victor; Lopez-Carmona Dolores; Calleja Fernando; Gomez-Huelgas Ricardo; Badimon Lina; Francisco J Tinahones
Journal:  Cardiovasc Diabetol       Date:  2012-07-24       Impact factor: 9.951

7.  Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase 9 expression in vascular smooth muscle cells.

Authors:  Maryam Saneipour; Keihan Ghatreh-Samani; Esfandiar Heydarian; Effat Farrokhi; Narges Abdian
Journal:  ARYA Atheroscler       Date:  2015-05

8.  Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.

Authors:  Magda Gioia; Giulia Vindigni; Barbara Testa; Sofia Raniolo; Giovanni Francesco Fasciglione; Massimiliano Coletta; Silvia Biocca
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.